On September 8, 2026 Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics for rare diseases with significant unmet needs, reported that Gilad Mamlok, Senior Vice President and Chief Financial Officer, is scheduled to participate in the following two upcoming investor conferences in New York City, New York:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
H.C. Wainwright 28th Annual Global Investment Conference
Date: September 14-16, 2026
Company Presentation Date & Time: Monday, September 14, 2026, 2:00 p.m. EDT
Morgan Stanley 24th Annual Global Healthcare Conference
Date: September 14-16, 2026
Fireside Chat Date & Time: Wednesday, September 16, 2026, 1:05 p.m. EDT
A live audio webcast of the Morgan Stanley fireside chat will be available at View Source, and on the Events Calendar of the Investors section of the Company’s website, www.protalix.com. An archived replay will be available following the event.
For more information or to schedule a one-on-one meeting with management, please contact your conference representative.
(Press release, Protalix, SEP 8, 2026, View Source [SID1234670633])